Brief: Sesen Bio Files Definitive Proxy Statement

Carisma Therapeutics

19/01/2023 21:42

Jan 19 (Reuters) - Sesen Bio Inc  SESN.O :
    * SESEN BIO FILES DEFINITIVE PROXY STATEMENT AND MAILS
LETTER TO
STOCKHOLDERS IN CONNECTION WITH PENDING MERGER WITH CARISMA
THERAPEUTICS
    * SESEN BIO-BOARD RECOMMENDS STOCKHOLDERS VOTE "FOR" EACH OF
PROPOSALS LISTED ON WHITE PROXY CARD ENCLOSED WITH DEFINITIVE
PROXY STATEMENT / PROSPECTUS
    * SESEN BIO INC - SCHEDULES MARCH 2, 2023, SPECIAL MEETING
OF
STOCKHOLDERS TO VOTE ON MERGER

Source text for Eikon:  ID:nBw9Wk2wga 
Further company coverage:  SESN.O 
 ((Reuters.Briefs@thomsonreuters.com;))